CL
TXG icon

Choreo LLC’s 10x Genomics TXG Stock Holding History

Choreo LLC’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
28,969
+1,084
+4% +$28.4K 0.01% 603
2026
Q1 		$592K Buy
27,885
+830
+3% +$16.6K 0.01% 849
2025
Q4 		$440K Buy
27,055
+4,010
+17% +$60.6K 0.01% 985
2025
Q3 		$269K Buy
23,045
+9,782
+74% +$128K ﹤0.01% 1294
2025
Q2 		$154K Buy
+13,263
New +$121K ﹤0.01% 1430

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Choreo LLC's TXG Position: Q2 2026 in Review

Choreo LLC increased its 10x Genomics (TXG) stake by 3.9% in Q2 2026, buying an estimated $28.4K and bringing the position to 28,969 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #603.

Choreo LLC first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Choreo LLC held 28,969 shares of 10x Genomics worth $1.11M as of Q2 2026.
  • Choreo LLC bought 1,084 10x Genomics shares in Q2 2026, an estimated $28.4K.
  • 10x Genomics made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #603 holding.
  • Choreo LLC first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.